Results 181 to 190 of about 1,694,068 (249)
Implementation of the Standards for adult immunization practice: A survey of U.S. Health care providers. [PDF]
Granade CJ +9 more
europepmc +1 more source
ABSTRACT Trust in childhood vaccination is a concern for health policy, particularly in settings of political transition and conflict, where governance, institutional legitimacy and service delivery are often under strain. It is against this backdrop that this study aims to describe evolving interactions between health system governance, trust and ...
Harriet Dwyer +7 more
wiley +1 more source
IAPSM's Position Paper on the Human Papilloma Virus (HPV) Vaccine for Adult Immunization in India. [PDF]
Shetty RS +9 more
europepmc +1 more source
Artificial intelligence and liquidation: Reality, destiny and fantasy
Abstract Artificial intelligence (AI) is increasingly reshaping the administration of corporate liquidation. Beyond its established role in financial prediction and data analytics, AI is now assisting insolvency practitioners in identifying the onset of financial distress, managing creditor communications, tracing and valuing assets and enhancing ...
Kai Zhang, Jingchen Zhao
wiley +1 more source
Response to "Adult Immunization Policy in Korea". [PDF]
Bhattacharya S, Bhattacharya S.
europepmc +1 more source
ABSTRACT All cases of invasive cervical cancer (ICC) and subsets of high‐grade cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3) and adenocarcinoma in situ (AIS) in Norway are tested for 37 human papillomavirus (HPV) genotypes, within a mandatory national surveillance system.
Terese Bekkevold +13 more
wiley +1 more source
A budget impact analysis of adult immunization with tetanus, diphtheria, and pertussis vaccination for the prevention of pertussis in at-risk populations in Colombia. [PDF]
Ahmed N +4 more
europepmc +1 more source
An Adult Immunization Best Practices Learning Collaborative: Impact, Scale Up, and Spread. [PDF]
Ciemins EL +8 more
europepmc +1 more source
ABSTRACT Objective Tofacitinib is a Janus kinase (JAK) inhibitor approved for the treatment of moderate‐to‐severe rheumatoid arthritis (RA). However, its synovium‐related molecular mechanisms, particularly its regulatory effect on fibroblast‐like synoviocyte (FLS) migration, remain incompletely understood.
Shuqi Fang +13 more
wiley +1 more source

